Stock Traders Buy High Volume of Put Options on Oscar Health (NYSE:OSCR)

Oscar Health, Inc. (NYSE:OSCR) was the target of some unusual options trading on Monday. Stock investors acquired 13,088 put options on the company. This represents an increase of approximately 60% compared to the average volume of 8,163 put options.

Hedge Funds Weigh In On Oscar Health

Several large investors have recently added to or reduced their stakes in OSCR. JPMorgan Chase & Co. grew its stake in shares of Oscar Health by 348.7% in the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock valued at $139,246,000 after purchasing an additional 8,051,379 shares during the period. BIT Capital GmbH grew its position in Oscar Health by 5,711.6% during the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock worth $60,129,000 after acquiring an additional 4,396,872 shares during the last quarter. Deerfield Management Company L.P. Series C grew its position in Oscar Health by 50.7% during the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company’s stock worth $159,062,000 after acquiring an additional 3,983,325 shares during the last quarter. Hennessy Advisors Inc. grew its position in Oscar Health by 550.3% during the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock worth $56,292,000 after acquiring an additional 3,544,300 shares during the last quarter. Finally, Gilder Gagnon Howe & Co. LLC grew its position in Oscar Health by 51.4% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company’s stock worth $85,154,000 after acquiring an additional 2,151,256 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Analyst Ratings Changes

OSCR has been the topic of a number of research analyst reports. Jefferies Financial Group began coverage on Oscar Health in a report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price target on the stock. Wells Fargo & Company downgraded Oscar Health from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Oscar Health currently has an average rating of “Hold” and an average price target of $20.19.

Oscar Health Price Performance

NYSE OSCR opened at $12.82 on Wednesday. Oscar Health has a twelve month low of $12.43 and a twelve month high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a market capitalization of $3.21 billion, a PE ratio of -640.43 and a beta of 1.75. The stock has a 50-day simple moving average of $15.16 and a 200 day simple moving average of $16.31.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Research analysts anticipate that Oscar Health will post 0.69 EPS for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.